Plain-English translation of NCT07329673 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is evaluating QbMobile, a 10-minute test you complete on your smartphone, to see how well it can help doctors tell the difference between conditions like autism, depression, bipolar disorder, and anxiety disorders. Right now, doctors diagnose these conditions based on interviews and observations, which can sometimes be confusing because the symptoms overlap. This study wants to see if QbMobile can give doctors an objective tool to help make faster, more accurate diagnoses.
Many people with mood, anxiety, and developmental disorders struggle to get the right diagnosis because their symptoms can look similar. This medication aims to give doctors a quick, objective way to distinguish between these conditions so patients can get the right treatment faster.
You likely qualify if…
You likely don't qualify if…
If you join, you'll complete the QbMobile test twice: once during a regular clinic visit (on your phone), and again the next day at home at roughly the same time. Each test takes about 10 minutes. You'll be asked to do this before starting any new treatment. The study is looking to enroll about 300 people total, and researchers will use the results to understand how well this app works at helping doctors make accurate diagnoses.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States
Sponsor
Qbtech AB
Enrollment target
~300 participants
Started
January 2026
Primary completion
November 2026
Age range
6 Years – 60 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Robert Nolen
Qbtech AB
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.